Protonix IV en es it fr

Protonix IV Brand names, Protonix IV Analogs

Protonix IV Brand Names Mixture

  • No information avaliable

Protonix IV Chemical_Formula


Protonix IV RX_link

Protonix IV fda sheet

Protonix_IV FDA

Protonix IV msds (material safety sheet)

Protonix_IV MSDS

Protonix IV Synthesis Reference

No information avaliable

Protonix IV Molecular Weight

383.371 g/mol

Protonix IV Melting Point

Because of gradual degradation of pantoprazole sodium during heating, the melting point cannot be determined.

Protonix IV H2O Solubility

Freely soluble in water.

Protonix IV State


Protonix IV LogP


Protonix IV Dosage Forms

Tablet (enteric-coated)

Protonix IV Indication

Short-term (up to 16 weeks) treatment of erosive esophagitis.

Protonix IV Pharmacology

Pantoprazole is a substituted benzimidazole indicated for the short-term treatment (up to 16 weeks) in the healing and symptomatic relief of erosive esophagitis. Pantoprazole is a proton pump inhibitor (PPI) that suppresses the final step in gastric acid production.

Protonix IV Absorption

Pantoprazole is well absorbed; it undergoes little first-pass metabolism resulting in an absolute bioavailability of approximately 77%.

Protonix IV side effects and Toxicity

No information avaliable

Protonix IV Patient Information

Patients should be cautioned that PROTONIX Delayed-Release Tablets should not be split, crushed or chewed. The tablets should be swallowed whole, with or without food in the stomach. Concomitant administration of antacids does not affect the absorption of pantoprazole.

Protonix IV Organisms Affected

Humans and other mammals